There are no new safety concerns around the Pfizer COVID-19 vaccine and heart inflammation based on the rollout of the shot in Britain, the UK MHRA medicine regulator said on Wednesday, after cases of the condition in Israel.
For more coronavirus news, visit our dedicated page.
“The MHRA is as aware of the reports of myocarditis under investigation in Israel. Based on our experience and safety monitoring in the UK, there is currently no new safety concerns raised regarding myocarditis,” a MHRA spokeswoman said.
The comment echoed the US Centers for Disease Control and Prevention (CDC) which said it had not seen a link between the shot and heart inflammation.
-Developing
Read more:
EU official warns of risks of disjointed COVID-19 vaccine records
Chinese vaccine makers consider combining COVID-19 jabs, booster shots
White House says it’s considering intellectual property waiver for COVID-19 vaccines
Also Read
-
Israel examining heart inflammation cases in people who received Pfizer COVID-19 shot
Israel’s Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer’s COVID-19 ... Coronavirus -
EU seals deal with Pfizer-BioNTech for up to 1.8 bln doses of coronavirus vaccine
The European Union sealed a deal with Pfizer-BioNTech for the supply of up to 1.8 billion doses of their COVID-19 vaccine, an EU official told ... Coronavirus -
Pfizer confirms fake COVID-19 shots on sale in Mexico, Poland: Reports
US drugmaker Pfizer on Wednesday confirmed that suspect doses of its coronavirus vaccine that were seized in Mexico and Poland were indeed fake, with ... Coronavirus
